| Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
|---|
| C002202 |
4-oxoretinoic acid |
4-oxoretinoic acid results in decreased expression of FLG mRNA | decreases expression | 15982314
|
| C103303 |
alitretinoin |
alitretinoin results in decreased expression of FLG mRNA | decreases expression | 15982314
|
| D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of FLG mRNA | affects expression | 16483693
|
| D004054 |
Diethylstilbestrol |
Diethylstilbestrol results in increased expression of FLG mRNA | increases expression | 15171707
|
| D010615 |
Phenacetin |
Phenacetin results in increased expression of FLG mRNA | increases expression | 17082564
|
| C030299 |
phenylhydrazine |
phenylhydrazine results in increased expression of FLG mRNA | increases expression | 17082564
|
| D015474 |
Isotretinoin |
Isotretinoin results in decreased expression of FLG mRNA | decreases expression | 15982314
|
| C009277 |
sodium arsenate |
sodium arsenate results in decreased expression of FLG mRNA | decreases expression | 12727804 11485391
|
| C017947 |
sodium arsenite |
sodium arsenite results in decreased expression of FLG mRNA | decreases expression | 12727804 11485391
|
| C017947 |
sodium arsenite |
sodium arsenite results in increased expression of FLG mRNA | increases expression | 19524636
|
| C017947 |
sodium arsenite |
sodium arsenite results in increased expression of FLG protein | increases expression | 19524636
|
| D013749 |
Tetrachlorodibenzodioxin |
AHR protein affects the reaction [Tetrachlorodibenzodioxin results in increased expression of FLG protein] | affects reaction|increases expression | 12151643
|
| D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of FLG protein | increases expression | 12151643
|
| D014212 |
Tretinoin |
Tretinoin metabolite results in increased expression of FLG mRNA | increases expression | 15982314
|
| D014212 |
Tretinoin |
Tretinoin results in decreased expression of FLG mRNA | decreases expression | 15982314
|
| Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
|---|
| MESH:D000014 |
Abnormalities, Drug-Induced |
|
Isotretinoin |
9.35 | 18769834 |
| MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
9.35 | 11752688 15322242 14514962 |
| MESH:D000015 |
Abnormalities, Multiple |
|
Isotretinoin |
5.12 | 18769834 |
| MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.75 | 18287403 |
| MESH:D017486 |
Acneiform Eruptions |
|
Isotretinoin |
6.50 | 16232082 |
| MESH:D000152 |
Acne Vulgaris |
|
Isotretinoin |
5.70 | 16185265 18769834 |
| MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
3.57 | 16835633 |
| MESH:D000310 |
Adrenal Gland Neoplasms |
|
sodium arsenite |
4.92 | 15276417 |
| MESH:D018246 |
Adrenocortical Adenoma |
|
sodium arsenite |
5.12 | 17306315 16712894 |
| MESH:D000505 |
Alopecia |
|
Tretinoin |
3.73 | 15955085 |
| MESH:D000686 |
Amyloidosis |
|
Diethylstilbestrol |
4.64 | 15469931 |
| MESH:D000740 |
Anemia |
|
Phenacetin |
15.93 | 2444515 |
| MESH:D000740 |
Anemia |
|
phenylhydrazine |
15.93 | 2444515 |
| MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
15.93 | 11748828 |
| MESH:D000743 |
Anemia, Hemolytic |
|
Phenacetin |
11.53 | 1949026 17698508 17082564 |
| MESH:D000743 |
Anemia, Hemolytic |
|
phenylhydrazine |
11.53 | 17698508 17084956 17082564 |
| MESH:D001169 |
Arthritis, Experimental |
|
Tretinoin |
3.16 | 16412693 |
| MESH:D001172 |
Arthritis, Rheumatoid |
|
Tretinoin |
2.29 | 16292516 |
| MESH:D001249 |
Asthma |
|
Tretinoin |
2.38 | 16456186 |
| MESH:D001471 |
Barrett Esophagus |
|
Tretinoin |
4.56 | 16935849 |
| MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
9.41 | 12125929 |
| MESH:D001778 |
Blood Coagulation Disorders |
|
Tretinoin |
9.41 | 16206674 16197459 |
| MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
4.01 | 15340226 |
| MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.85 | 15746008 |
| MESH:D001943 |
Breast Neoplasms |
|
alitretinoin |
2.01 | 16344269 |
| MESH:D001943 |
Breast Neoplasms |
|
Diethylstilbestrol |
2.01 | 15324884 17129689 |
| MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
2.01 | 20435547 |
| MESH:D001943 |
Breast Neoplasms |
|
Tretinoin |
2.01 | 16873071 16443354 16166294 |
| MESH:D001997 |
Bronchopulmonary Dysplasia |
|
Tretinoin |
4.78 | 16813970 |
| MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.91 | 16835633 |
| MESH:D018236 |
Carcinoma, Embryonal |
|
Tretinoin |
5.38 | 16168501 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
Diethylstilbestrol |
4.78 | 15948411 16924424 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
sodium arsenite |
4.78 | 17306315 15276417 16507464 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tretinoin |
4.78 | 1917145 |
| MESH:D002294 |
Carcinoma, Squamous Cell |
|
Isotretinoin |
7.91 | 11237771 |
| MESH:D002294 |
Carcinoma, Squamous Cell |
|
sodium arsenite |
7.91 | 18572023 |
| MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tretinoin |
7.91 | 16051514 16096774 |
| MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.44 | 16120746 18670907 18850075 |
| MESH:D002386 |
Cataract |
|
Tretinoin |
3.17 | 17460283 |
| MESH:D002471 |
Cell Transformation, Neoplastic |
|
sodium arsenite |
3.08 | 19524636 20056578 |
| MESH:D018290 |
Cervical Intraepithelial Neoplasia |
|
Tretinoin |
4.78 | 16129372 |
| MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.29 | 16835633 |
| MESH:D002822 |
Choriocarcinoma |
|
Tretinoin |
5.38 | 16461808 |
| MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
5.94 | 12621046 15340226 15668235 8697196 16354765 |
| MESH:D002972 |
Cleft Palate |
|
Tretinoin |
5.94 | 9407595 |
| MESH:D003092 |
Colitis |
|
Tretinoin |
3.88 | 17035595 |
| MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.18 | 17141729 14669216 |
| MESH:D019465 |
Craniofacial Abnormalities |
|
Isotretinoin |
5.60 | 9879862 18769834 |
| MESH:D019465 |
Craniofacial Abnormalities |
|
sodium arsenate |
5.60 | 10525206 |
| MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
5.60 | 10048152 20055451 15322242 |
| MESH:D019465 |
Craniofacial Abnormalities |
|
Tretinoin |
5.60 | 9664655 10589399 14991402 16925845 9125849 17551590 9211117 9142499 9224671 8800419 |
| MESH:D003456 |
Cryptorchidism |
|
Diethylstilbestrol |
4.72 | 16002989 12952375 |
| MESH:D003876 |
Dermatitis, Atopic |
marker/mechanism |
|
| 19349982 |
| MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.69 | 17107852 |
| MESH:D056486 |
Drug-Induced Liver Injury |
|
sodium arsenate |
4.20 | 18186108 |
| MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
4.20 | 20420201 |
| MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.86 | 11462148 |
| MESH:D004485 |
Eczema |
marker/mechanism |
|
| 17417636 |
| MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
2.51 | 11000095 12711302 |
| MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
12.68 | 16714409 15322242 18230668 |
| MESH:D004489 |
Edema, Cardiac |
|
Tretinoin |
12.68 | 18230668 |
| MESH:D004714 |
Endometrial Hyperplasia |
|
Diethylstilbestrol |
4.89 | 16402032 |
| MESH:D016889 |
Endometrial Neoplasms |
|
Diethylstilbestrol |
7.89 | 16804899 15700306 |
| MESH:D016889 |
Endometrial Neoplasms |
|
Tretinoin |
7.89 | 16569247 |
| MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
3.15 | 10568697 9294722 |
| MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
9.18 | 11564622 |
| MESH:D005124 |
Eye Abnormalities |
|
Tretinoin |
9.18 | 9664655 16938888 |
| MESH:D052776 |
Female Urogenital Diseases |
|
Diethylstilbestrol |
3.73 | 16002989 16611131 16534752 16513791 15751030 |
| MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.63 | 11858732 |
| MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
9.21 | 20067830 |
| MESH:D005355 |
Fibrosis |
|
Tretinoin |
9.21 | 17994277 |
| MESH:D005833 |
Genital Neoplasms, Female |
|
Diethylstilbestrol |
13.47 | 16452187 |
| MESH:D005833 |
Genital Neoplasms, Female |
|
sodium arsenite |
13.47 | 16452187 |
| MESH:D005909 |
Glioblastoma |
|
Tretinoin |
3.09 | 17312396 |
| MESH:D018149 |
Glucose Intolerance |
|
sodium arsenate |
5.23 | 19446573 |
| MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.81 | 10696789 |
| MESH:D006258 |
Head and Neck Neoplasms |
|
Tretinoin |
3.27 | 16096774 |
| MESH:D006317 |
Hearing Loss, Noise-Induced |
|
Tretinoin |
5.38 | 16084493 |
| MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
6.76 | 10048152 11294989 |
| MESH:D006330 |
Heart Defects, Congenital |
|
Tretinoin |
6.76 | 9664655 14991402 |
| MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.48 | 11000095 |
| MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
3.07 | 15340226 16120746 12621046 |
| MESH:D006689 |
Hodgkin Disease |
|
sodium arsenite |
3.27 | 12676792 |
| MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.26 | 18606429 8697196 16354765 15340226 16959395 |
| MESH:D006930 |
Hyperalgesia |
|
Tretinoin |
3.32 | 16870215 |
| MESH:D017681 |
Hypereosinophilic Syndrome |
|
Tretinoin |
4.74 | 16778211 |
| MESH:D006965 |
Hyperplasia |
|
Diethylstilbestrol |
4.61 | 12960047 14722030 |
| MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
1.95 | 18850075 18670907 |
| MESH:D007021 |
Hypospadias |
|
Diethylstilbestrol |
4.75 | 16002989 |
| MESH:D016112 |
Ichthyosis Vulgaris |
marker/mechanism |
|
| 17417636 |
| MESH:D007246 |
Infertility |
|
Diethylstilbestrol |
4.52 | 15036965 |
| MESH:D007248 |
Infertility, Male |
|
sodium arsenite |
3.08 | 12646999 15346721 |
| MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
1.92 | 12200463 12878042 |
| MESH:D007410 |
Intestinal Diseases |
|
Tretinoin |
3.94 | 17994277 |
| MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
10.40 | 16580747 |
| MESH:D007569 |
Jaw Abnormalities |
|
Tretinoin |
10.40 | 15992940 17551590 |
| MESH:D017492 |
Keratosis, Seborrheic |
|
alitretinoin |
5.83 | 16144296 |
| MESH:D007674 |
Kidney Diseases |
|
sodium arsenite |
2.87 | 20008137 |
| MESH:D007680 |
Kidney Neoplasms |
|
Diethylstilbestrol |
3.58 | 15003126 14681315 16762066 |
| MESH:D007859 |
Learning Disorders |
|
Diethylstilbestrol |
4.24 | 17184923 |
| MESH:D007938 |
Leukemia |
|
Tretinoin |
2.83 | 17143497 |
| MESH:D007951 |
Leukemia, Myeloid |
|
Tretinoin |
3.84 | 16482212 19285840 16932348 |
| MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Tretinoin |
2.10 | 17596541 19850784 16294345 |
| MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Tretinoin |
3.24 | 19075265 17217047 17339181 17368321 16788101 16766008 17361223 16140955 17107899 15748426 16891316 17506722 9834237 17712046 19642359 12679006 19035177 16331271 16823087 17301526 17649720 19225113 19029980 17294898 16935935 |
| MESH:D017880 |
Limb Deformities, Congenital |
|
Tretinoin |
3.41 | 9224671 |
| MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
2.34 | 12878042 |
| MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tretinoin |
2.34 | 18397230 16248980 |
| MESH:D008113 |
Liver Neoplasms |
|
Diethylstilbestrol |
7.75 | 15890375 16712894 |
| MESH:D008113 |
Liver Neoplasms |
|
sodium arsenite |
7.75 | 16712894 15276417 |
| MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
7.75 | 16984957 |
| MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
2.19 | 12151625 |
| MESH:D008171 |
Lung Diseases |
|
sodium arsenite |
3.26 | 19095001 |
| MESH:D008175 |
Lung Neoplasms |
|
alitretinoin |
5.06 | 16413115 |
| MESH:D008175 |
Lung Neoplasms |
|
Isotretinoin |
5.06 | 15899809 |
| MESH:D008175 |
Lung Neoplasms |
|
sodium arsenite |
5.06 | 16712894 17077188 19931552 17306315 15276417 |
| MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
5.06 | 11884234 19555203 |
| MESH:D008181 |
Lupus Nephritis |
|
Diethylstilbestrol |
5.34 | 15166399 |
| MESH:D008223 |
Lymphoma |
|
Diethylstilbestrol |
3.57 | 15700306 |
| MESH:D052801 |
Male Urogenital Diseases |
|
Diethylstilbestrol |
5.73 | 16002989 |
| MESH:D008527 |
Medulloblastoma |
|
Tretinoin |
2.83 | 17453147 |
| MESH:D008545 |
Melanoma |
|
Isotretinoin |
5.38 | 17237267 |
| MESH:D008545 |
Melanoma |
|
sodium arsenite |
5.38 | 16487513 19082730 |
| MESH:D008545 |
Melanoma |
|
Tretinoin |
5.38 | 16752155 |
| MESH:D008591 |
Meningomyelocele |
|
Tretinoin |
4.60 | 16940565 |
| MESH:D008708 |
Methemoglobinemia |
|
Phenacetin |
5.10 | 16296465 4834387 3537620 1949026 |
| MESH:D009139 |
Musculoskeletal Abnormalities |
|
sodium arsenate |
5.00 | 18186108 |
| MESH:D009190 |
Myelodysplastic Syndromes |
|
Tretinoin |
3.15 | 17596541 |
| MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
3.13 | 12213967 |
| MESH:D009369 |
Neoplasms |
|
alitretinoin |
12.48 | 16946489 |
| MESH:D009369 |
Neoplasms |
|
Diethylstilbestrol |
12.48 | 15313581 |
| MESH:D009369 |
Neoplasms |
|
sodium arsenite |
12.48 | 11559025 |
| MESH:D009369 |
Neoplasms |
|
Tretinoin |
12.48 | 16594593 16946489 |
| MESH:D009374 |
Neoplasms, Experimental |
|
sodium arsenite |
3.84 | 20056578 |
| MESH:D009421 |
Nervous System Malformations |
|
Diethylstilbestrol |
17.37 | 11399458 |
| MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
17.37 | 14600291 |
| MESH:D009421 |
Nervous System Malformations |
|
Tretinoin |
17.37 | 9125849 |
| MESH:D009436 |
Neural Tube Defects |
|
sodium arsenate |
12.79 | 11749123 19446573 10525206 18186108 |
| MESH:D009436 |
Neural Tube Defects |
|
sodium arsenite |
12.79 | 12854658 |
| MESH:D009436 |
Neural Tube Defects |
|
Tretinoin |
12.79 | 9142499 |
| MESH:D009447 |
Neuroblastoma |
|
Isotretinoin |
4.11 | 17368321 |
| MESH:D010051 |
Ovarian Neoplasms |
|
sodium arsenite |
5.01 | 15276417 17306315 |
| MESH:D010051 |
Ovarian Neoplasms |
|
Tretinoin |
5.01 | 16936753 |
| MESH:D010146 |
Pain |
|
Tretinoin |
3.02 | 16870215 |
| MESH:D010190 |
Pancreatic Neoplasms |
|
Tretinoin |
2.50 | 15976015 |
| MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.47 | 12520081 |
| MESH:D010900 |
Pituitary Diseases |
|
Diethylstilbestrol |
5.39 | 14722030 |
| MESH:D010911 |
Pituitary Neoplasms |
|
Diethylstilbestrol |
4.85 | 15687265 16977796 |
| MESH:D017499 |
Porokeratosis |
|
alitretinoin |
6.22 | 16144296 |
| MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.72 | 18163543 |
| MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Diethylstilbestrol |
17.59 | 17184923 |
| MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Isotretinoin |
17.59 | 18769834 |
| MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
17.59 | 11118676 11896295 11222880 11399792 |
| MESH:D011471 |
Prostatic Neoplasms |
|
Diethylstilbestrol |
3.37 | 15046698 15846301 17136230 |
| MESH:D011471 |
Prostatic Neoplasms |
|
sodium arsenite |
3.37 | 16039940 |
| MESH:D011507 |
Proteinuria |
|
Tretinoin |
3.75 | 16636307 |
| MESH:D011596 |
Psychomotor Disorders |
|
Isotretinoin |
6.11 | 18769834 |
| MESH:D011625 |
Pterygium |
|
Tretinoin |
4.99 | 16723453 |
| MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
4.00 | 18990726 |
| MESH:D012208 |
Rhabdomyosarcoma |
|
Tretinoin |
4.25 | 16116481 16283617 |
| MESH:D012878 |
Skin Neoplasms |
|
sodium arsenite |
9.79 | 19524636 18572023 |
| MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
9.79 | 16192470 |
| MESH:D012878 |
Skin Neoplasms |
|
Tretinoin |
9.79 | 16467112 |
| MESH:D013088 |
Spermatocele |
|
Diethylstilbestrol |
4.93 | 16002989 16709447 |
| MESH:D016135 |
Spinal Dysraphism |
|
sodium arsenite |
3.90 | 12854658 |
| MESH:D013274 |
Stomach Neoplasms |
|
Tretinoin |
1.80 | 17261132 |
| MESH:D013436 |
Sulfhemoglobinemia |
|
Phenacetin |
6.77 | 978859 |
| MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
4.12 | 12697716 |
| MESH:D013964 |
Thyroid Neoplasms |
|
Tretinoin |
3.13 | 16026305 17045167 |
| MESH:D014062 |
Tongue Neoplasms |
|
Tretinoin |
3.92 | 16051514 |
| MESH:D014376 |
Tuberculosis |
|
Tretinoin |
3.31 | 16040207 |
| MESH:D001749 |
Urinary Bladder Neoplasms |
|
Diethylstilbestrol |
8.87 | 16712894 17306315 16452187 |
| MESH:D001749 |
Urinary Bladder Neoplasms |
|
Phenacetin |
8.87 | 11144890 |
| MESH:D001749 |
Urinary Bladder Neoplasms |
|
sodium arsenite |
8.87 | 16712894 17306315 11723127 16452187 |
| MESH:D002583 |
Uterine Cervical Neoplasms |
|
Diethylstilbestrol |
16.67 | 16175088 |
| MESH:D002583 |
Uterine Cervical Neoplasms |
|
sodium arsenite |
16.67 | 11813266 |
| MESH:D002583 |
Uterine Cervical Neoplasms |
|
Tretinoin |
16.67 | 16129372 |
| MESH:D014591 |
Uterine Diseases |
|
Diethylstilbestrol |
5.39 | 14652134 |
| MESH:D014594 |
Uterine Neoplasms |
|
Diethylstilbestrol |
4.23 | 15809267 16690809 |
| MESH:D014604 |
Uveal Neoplasms |
|
Tretinoin |
4.83 | 16752155 |
| MESH:D014625 |
Vaginal Neoplasms |
|
Diethylstilbestrol |
4.61 | 16002989 16513791 |
| MESH:D014652 |
Vascular Diseases |
|
sodium arsenite |
4.62 | 17056641 |
| MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.81 | 12125929 |
| MESH:D014820 |
Vitiligo |
|
Tretinoin |
4.22 | 16761959 |
| MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.47 | 15886252 |
| MESH:D009396 |
Wilms Tumor |
|
Tretinoin |
4.09 | 16287080 |